Vistagen Therapeutics, Inc. Class Action Lawsuit

Company: Vistagen Therapeutics, Inc.

Ticker: (NASDAQ) VTGN

Class Action Period: April 1, 2024 - December 16, 2025

11 Days LeftLead Plaintiff Deadline: March 16, 2026

See If You Qualify For Monetary Reward

Join the Vistagen Therapeutics, Inc. Class Action Lawsuit

There is no cost or obligation for you to submit.

The submission of this form does not create an attorney-client relationship.

CLASS ACTION PERIOD

April 1, 2024 - December 16, 2025

Allegations

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning its Phase 3 PALISADE-3 trial study of fasedienol, an investigational pherine candidate in development for the acute treatment of social anxiety disorder. On December 17, 2025, Vistagen issued a press release announcing that the PALISADE-3 Phase 3 study of intranasal fasedienol for the acute treatment of social anxiety disorder did not demonstrate a statistically significant improvement on the primary endpoint of change on the Subjective Units of Distress Scale. In pertinent part, defendants announced the trial did not achieve its primary endpoint and there was no treatment difference between fasedienol and placebo for the secondary endpoints. Following this news, the price of Vistagen’s common stock declined dramatically from a closing market of $4.36 per share on December 16, 2025 to $0.86 per share on December 17, 2025, a decline of more than 80%.

Eligibility

Eligibility

To join the lawsuit, you must have experienced a loss on Vistagen shares purchased within the class period specified above.

Lead Plaintiff Deadline

Lead Plaintiff Deadline

If you suffered a loss in Vistagen Therapeutics, Inc. during the relevant time frame, you have until March 16, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

EXPLORE MORE CASES

BlackRock TCP Capital Corp.

TCPC

Lead Plaintiff Deadline: April 6, 2026

Class Period: November 6, 2024 - January 23, 2026

32 Days Left

Mereo BioPharma Group plc

MREO

Lead Plaintiff Deadline: April 6, 2026

Class Period: June 5, 2023 - December 26, 2025

32 Days Left

Picard Medical, Inc.

PMI

Lead Plaintiff Deadline: April 3, 2026

Class Period: September 2, 2025 - October 31, 2025

29 Days Left

Case Podcast